Kinetics of fluphenazine after fluphenazine dihydrochloride, enanthate and decanoate administration to man.

SH Curry, PJ de Schepper, Stijn Vranckx, AA Schiff

British Journal of Clinical Pharmacology · 1979 · 85 citations · 10 references

DOIFull text

Open access

Concepts

Abstract

1 Fluphenazine (1,2-ethanol 14C) was administered to seven human subjects as the dihydrochloride and as the enanthate and decanoate esters. 2 The subjects had previously been treated with fluphenazine injections for at least 6 months. 3 Fluphenazine was separated from its radioactive metabolites by selective solvent extraction. Plasma concentrations were measured for up to 21 days after dosing. 4 The preparations showed differences in peak concentrations, times of the peaks and half-times of the elimination phase. The longest half-times occurred with the decanoate and the shortest with the dihydrochloride. 5 It is postulated that the differences in kinetics relate principally to the release of the compound from the site of injection. 6 There was no evidence for presence of the esters in plasma, urine or faeces.

References

10